Holen Sie sich die Stockscreener-App
78.99
0.42%
0.33
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$78.66
Offen:
$79.05
24-Stunden-Volumen:
4.18M
Relative Volume:
0.60
Marktkapitalisierung:
$100.19B
Einnahmen:
$393.94B
Nettoeinkommen (Verlust:
$428.00M
KGV:
206.46
EPS:
0.3826
Netto-Cashflow:
$6.29B
1W Leistung:
+1.07%
1M Leistung:
+2.42%
6M Leistung:
+18.28%
1J Leistung:
+38.41%
1-Tages-Spanne:
$78.29
$79.44
1-Wochen-Bereich:
$77.43
$79.86
52-Wochen-Spanne:
$43.56
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
78.99 | 99.85B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
324.21 | 291.28B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
317.78 | 69.88B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
264.58 | 68.49B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
252.04 | 30.20B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Health Corporation $CVS Shares Sold by Sigma Planning Corp - MarketBeat
Jim Cramer on CVS CEO: “I Really Like What David Joyner’s Doing With the Turnaround” - Insider Monkey
CVS Health: Can Its New PBM Strategy Finally Cut America’s Drug Costs? - Smartkarma
E-Pharmacy Market Set to Quadruple, Reaching USD 435.82 Billion by 2034, Reports Towards Healthcare - GlobeNewswire Inc.
What the charts say about CVS Health Corporation todayWall Street Watch & Low Drawdown Trading Strategies - newser.com
Will CVS Health Corporation bounce back from current supportCPI Data & Fast Gaining Stock Strategy Reports - newser.com
CVS Health Corporation $CVS Shares Purchased by Achmea Investment Management B.V. - MarketBeat
Will CVS Health Corporation (CVS) stock beat revenue estimates2025 Trade Ideas & Free Accurate Trade Setup Notifications - newser.com
Patients win when healthcare providers and insurers come together | Column - Tampa Bay Times
Can CVS Health Corporation (Common Stock) (CVS0) stock reach $200 price targetProduct Launch & AI Powered Market Entry Ideas - newser.com
Should you wait for a breakout in CVS Health CorporationInsider Selling & AI Enhanced Trading Alerts - newser.com
Short interest data insights for CVS Health CorporationTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Will CVS Health Corporation stock benefit from automation2025 Volume Leaders & Safe Entry Zone Tips - fcp.pa.gov.br
Is CVS Health Corporation stock positioned for secular growth2025 Price Targets & Community Consensus Trade Signals - fcp.pa.gov.br
Cushman & Wakefield Brokers $57M Sale of Distribution Center in Orlando - REBusinessOnline
CVS class action alleges company charged illegal tobacco surcharge - Class Action Lawsuits
NewSquare Capital LLC Purchases 4,854 Shares of CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation (Common Stock) (CVS0) stock a safe buy pre earningsQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
NJ State Employees Deferred Compensation Plan Decreases Holdings in CVS Health Corporation $CVS - MarketBeat
Will CVS Health Corporation (CVS) stock maintain strong growthMarket Activity Report & Safe Capital Allocation Plans - newser.com
Is CVS Health Corporation stock positioned for digital transformationQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
CVS Unit Omnicare Taps Alvarez & Marsal for Operational Help - MSN
TD Cowen Increases CVS Health (NYSE:CVS) Price Target to $100.00 - MarketBeat
Florida firm buys massive CVS-leased distribution facility for $57M, signaling shift in investment strategy - The Business Journals
Bank of New York Mellon Corp Sells 325,652 Shares of CVS Health Corporation $CVS - MarketBeat
Hussman Strategic Advisors Inc. Takes $2.17 Million Position in CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation stock supported by strong fundamentalsEarnings Growth Report & Low Risk Entry Point Guides - newser.com
Y Intercept Hong Kong Ltd Acquires New Position in CVS Health Corporation $CVS - MarketBeat
Why global investors buy CVS Health Corporation stockJuly 2025 EndofMonth & Real-Time Volume Triggers - newser.com
CVS Sees Target Price Raised by TD Cowen Analyst Amidst Continua - GuruFocus
CVS Health price target raised to $100 from $99 at TD Cowen - TipRanks
CVS Health (NYSE:CVS) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat
CVS Health: Undervalued And Ripe For Growth (NYSE:CVS) - Seeking Alpha
CVS Health Corporation $CVS Stake Lowered by Triglav Investments D.O.O. - MarketBeat
Versor Investments LP Increases Stake in CVS Health Corporation $CVS - MarketBeat
Burney Co. Decreases Position in CVS Health Corporation $CVS - MarketBeat
4,657 Shares in CVS Health Corporation $CVS Bought by Sebold Capital Management Inc. - MarketBeat
AlphaStar Capital Management LLC Makes New $385,000 Investment in CVS Health Corporation $CVS - MarketBeat
State of Michigan Retirement System Has $27.12 Million Position in CVS Health Corporation $CVS - MarketBeat
Welch & Forbes LLC Trims Stake in CVS Health Corporation $CVS - MarketBeat
GHP Investment Advisors Inc. Buys 6,476 Shares of CVS Health Corporation $CVS - MarketBeat
IFG Advisory LLC Sells 4,071 Shares of CVS Health Corporation $CVS - MarketBeat
Spire Wealth Management Sells 64,594 Shares of CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation stock affected by interest rate hikesMarket Performance Report & Growth Focused Investment Plans - newser.com
Is now a turning point for CVS Health Corporation2025 Major Catalysts & Real-Time Stock Entry Alerts - newser.com
How CVS Health Corporation (CVS) stock performs in easing cyclesProduct Launch & Safe Swing Trade Setup Alerts - newser.com
Is CVS Health Corporation stock a buy for dividend growth2025 EndofYear Setup & Stock Portfolio Risk Control - newser.com
CVS Health (NYSE:CVS) Price Target Raised to $90.00 - MarketBeat
CVS Health (NYSE:CVS) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Is Wall Street Bullish or Bearish on CVS Health Stock? - MSN
6,521 Shares in CVS Health Corporation $CVS Acquired by Syverson Strege & Co - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):